Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin
- PMID: 17692793
- PMCID: PMC7111659
- DOI: 10.1016/j.healun.2007.05.020
Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin
Abstract
Human metapneumovirus (hMPV) has recently been shown to be a prominent cause of respiratory infections in immunocompromised hosts, and is associated with high morbidity and mortality. We report a case of hMPV pneumonia in a lung transplant recipient presenting with respiratory failure and sepsis syndrome. hMPV was diagnosed by polymerase chain reaction, and treated with intravenous ribavirin with a successful outcome.
Figures
References
-
- Chan K.M. Approach towards infectious pulmonary complications in lung transplant recipients. In: Singh N., Aguado J.M., editors. Infectious complications in transplant patients. Kluwer Academic; Dordrecht, The Netherlands: 2001. pp. 149–175.
-
- Larcher C., Geltner C., Fischer H., Nachbaur D., Muller L.C., Huemer H.P. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant. 2005;24:1891–1901. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical